People in the News

Nov 13, 2017

Eric Johnson, Ashley Kiley

Tenet Diagnostics has appointed Eric Johnson as director of laboratory services and Ashley Kiley as director of provider relations. Johnson is joining Tenet from Advanced Clinical Laboratory Solutions (ACLS), where he serves as laboratory director. He has also been a laboratory director at Iverson Genetics and Parabase Genomics. Kiley will also join Tenet from ACLS, where she serves as sales director. She has also served as a marketing manager for Pain Physicians NY.

Nov 10, 2017

John Gu

WuXi NextCode has hired John Gu as chief digital officer. A former CIO of Chinese internet service provider and search engine Baidu, Gu comes to the genomic data firm from consulting firm Silver Sand Technologies. At WuXi NextCode, the US-educated Gu will lead expansion of the company's data platform in China.

Nov 09, 2017

Doug Liu, Mark Gladwell, Laura Furmanski

Doug Liu is retiring from his role as senior vice president of global operations at Qiagen, CEO Peer Schatz said during an earnings call this week. He will be succeeded by Mark Gladwell, who joined the company from Alere, where he most recently served as senior vice president of global operations. 

In addition, Schatz said that Laura Furmanski, senior vice president of the bioinformatics business area, has resigned from the company. A search for her successor is in an advanced stage, Schatz said.

Nov 08, 2017

Nicholas Potter

Nicholas Potter joined Epigenomics as director of reimbursement and medical affairs, effective Nov. 1. In his position, he will create the firm's reimbursement strategy for its blood-based menu of methylated cancer detection technologies. Most recently, Potter was at MPLN as laboratory director of molecular diagnostics, CSO, and finally executive vice president of clinical affairs. 

Nov 08, 2017

Gary Guthart

Illumina has named Gary Guthart to its board of directors, effective Dec. 1, 2017. Guthart is president and CEO of Intuitive Surgical, which makes robots to assist with minimally invasive surgery. He has held a variety of roles at Intuitive Surgical since 1996 and previously developed foundational technology for computer-enhanced surgery at SRI International, which was formerly the Stanford Research Institute. He also served on the board of directors at Affymetrix from 2009 until it was acquired by Thermo Fisher Scientific in 2016.

Nov 07, 2017

Harold Rabinovitz

Dermtech announced today that it has appointed Harold Rabinovitz to its scientific advisory board. Rabinovitz currently serves as a volunatary clinical professor of dermatology at the University of Miami School of Medicine. 

Nov 06, 2017

Lily Sarafan

Home Care Assistance CEO Lily Sarafan has joined the board of Counsyl. She also serves on the boards of AI company Entefy, the Stanford Alumni Association, and the Berkeley Haas Center for Innovation Economies. 

Nov 06, 2017

Jorge Garces

Epigenomics has appointed Jorge Garces as president and CSO, effective Dec. 1. He will join the firm's executive board and oversee operations, R&D, clinical affairs, regulatory and quality. Prior to joining Epigenomics, Garces was CEO and president of AltheaDx. Before that, he held the same positions at Enigma Diagnostics. He also has held management positions at Hologic and GenMark Diagnostics, as well as Third Wave Technologies. 

Nov 03, 2017

Kathy Ordoñez

Pacific Biosciences has hired Kathy Ordoñez as chief commercial officer. Ordoñez has been a member of PacBio's board of directors since 2014 and will continue in that role, as well. Ordoñez was most recently CEO of RainDance Technologies. She was also previously senior vice president at Quest Diagnostics where she led the company's R&D efforts and provided oversight to businesses commercializing diagnostic products and testing services. She served as CEO at Celera and was a founder of Celera Diagnostics before the company was acquireid by Quest Diagnostics. She also held several positions at Hoffmann-La Roche, including overseeing the formation of Roche Molecular Systems.

Nov 03, 2017

Hayden Jeffreys, Joanne Mason

Cambridge Epigenetix has appointed Hayden Jeffreys as chief operating officer and Joanne Mason as vice president of biomarker discovery. Jeffreys has previously served as interim CEO of Erba Diagnostics, as well as head of corporate business development and strategy for Erba Mannheim and Lumora. He has also held senior positions at Lab21 and Gen-Probe (now part of Hologic).

Mason was previously director of sequencing and sample acquisition for Genomics England, where she managed sample collection and sequencing for the 100,000 Genomes Project. She also set up and managed an NGS core facility at Oxford University Hospitals NHS Foundation Trust. She holds a PhD from the University of Cambridge and sits on the MHRA Genomics for Diagnosis Forum, UK NEQAS for molecular genetics DNA extraction steering committee, and Genomics England sequencing advisory board.

Nov 03, 2017

Pat Brooks, Rebecca Galler, Keith Jones

Mission Bio has hired Pat Brooks as senior vice president of sales and sales operations, Rebecca Galler as senior vice president of marketing, and Keith Jones as senior vice president of product development.  

Brooks was previously vice president of global sales and development at Cellular Dynamics International. Prior to that, he held vice president positions at Ion Torrent, Pacific Biosciences, and Affymetrix. Brooks has a master of science and a bachelor of science degree from the University of Iowa.

Galler previously was previously involved in strategic marketing for Qventus and Castlight Health. In the past, she was head of corporate strategy at Sirna Therapeutics, director of private equity at Invesco Funds Group, and vice president of marketing at Preferred Global Health. She holds an MBA from Columbia University and a BA from Barnard College.

Jones used to be senior vice president of molecular assay research and development at Verinata Health, now part of Illumina. In the past, he was vice president of molecular genetics at Affymetrix. He holds a PhD in pharmacology from Stanford University School of Medicine and undergraduate degrees in chemistry and biological sciences from the University of California, Irvine.

Nov 03, 2017

Clive Brown

Clive Brown has been appointed as a director of Oxford Nanopore Technologies. He is the company's chief technology officer.

Oct 31, 2017

Ulrich Mueller

Ulrich Mueller has joined Sengine Precision Medicine as its chief business officer, effective Nov. 1. He previously was COO of Bio-Path Holding. Before that, he served as vice president of industry relation and clinical research support at the Fred Hutchinson Cancer Research Center and was managing director of technology commercialization at the University of Texas MD Anderson Cancer Center. 

Oct 31, 2017

Linday Avey, Michele Cargill, Geoffrey Ginsburg, Stuart Kim, and Eric Rasmussen

Exploragen has appointed Linday Avey, Michele Cargill, Geoffrey Ginsburg, Stuart Kim, and Eric Rasmussen to its advisory board. Avey is a co-founder of 23andMe and of, as well as a member of the Board of Fellows at Stanford University School of Medicine; Cargill is a co-founder and fellow at Invitae; Ginsburg is professor of medicine and biomedical engineering at Duke University and the founder of the Global Genomic Medicine Collaborative; Rasmussen is vice president of consumer insights at Groupon; and Kim is professor emeritus of developmental biology and genetics at Stanford University. 

Oct 31, 2017

Pascale Witz

PerkinElmer has elected Pascale Witz to its board of directors, effective immediately. Witz most recently served as executive vice president of Sanofi's global diabetes and cardiovascular business. Prior to that, she held several leadership positions during 17 years with GE Healthcare, including president and CEO of its medical diagnostics division. Witz also currently serves on the boards of Horizon Pharma, Regulus Therapeutics, Fresenius Medical Care, Savencia, and French-American Foundation-France.

Oct 27, 2017

Trudy Mackay

Trudy Mackay was recently named director of Clemson University's Center for Human Genetics. Mackay is currently a distinguished university professor and distinguished chair of biological sciences at North Carolina State University. She is also member of the National Academy of Sciences and the Royal Society. She will officially start her new position at Clemson in July 2018.

Oct 27, 2017

Joshua Mann

Joshua Mann has joined Inspirata as vice president of the company's Cancer Information Data Trust. He will be responsible for aligning the CIDT business strategy with systems design and data flow, spanning data collection, organization and management, as well as data analysis and visualization. Mann has previously served as director of oncology technology solutions and acting chief technology officer for CancerLinQ, a subsidiary or the American Society of Clinical Oncology. He also cofounded SHARE for Cures, a non-profit organization that seeks to empower patients to use their individual health data to advance medical research. Immediately prior to joining Inspirata, Mann ran a consulting firm through which he served as a consulting chief information officer to Guardian Research Network.

Oct 26, 2017

Shalini Verma, B.G. Jones

PieranDx has named board-certified pathologist Shalini Verma as laboratory and medical director, in charge of growing the company's clinical genomics product line. St. Louis-based Pieran Dx also hired B.G. Jones as senior vice president of business development. Health IT veteran Jones is chair of the Healthcare Information and Management Systems Society's Precision Medicine Work Group and a member of the Global Alliance for Genomics & Health and the Precision Medicine Coalition. 

Oct 26, 2017

Inivata Scientific Advisory Board

Inivata has announced formation of a new scientific advisory board, chaired by Edward Kim of the Levine Cancer Institute. Kim currently serves as a distinguished chair for cancer research and chairman of solid tumor oncology and investigational therapeutics at Levine.

Also joining the board are Benjamin Besse, Ramaswamy Govindan, Geoffrey Oxnard, Lee Schwartzberg, and Sandra Swain. Besse is chairman of the thoracic unit at Gustave Roussy Cancer Center in Paris. Govindan is a professor of medicine and a chair of medical oncology at Washington University School of Medicine. Oxnard is a thoracic oncologist at the Dana-Farber Cancer Institute and an assistant professor at Harvard Medical School. Schwartzberg is executive director of the West Cancer Center and chief of the division of hematology/oncology at the University of Tennessee Health Science Center. He is also the president and chief medical officer of Vector Oncology and serves on the board of directors of the National Comprehensive Cancer Network. Swain serves as a professor and associate dean for research and development at the Georgetown University School of Medicine.

Oct 23, 2017

Daniel Siegel

DermTech has appointed Daniel Siegel to its scientific advisory board. Siegel is currently a clinical professor of dermatology at SUNY Downstate. He has served as president of the American Academy of Dermatology and is a past member of both the Academy's board of directors and its coding and reimbursement task force. 

Oct 19, 2017

Douglas Berthiaume, Christopher O'Connell

Douglas Berthiaume is retiring as chairman of Waters' board, effective Dec. 31, 2017. Waters President and CEO Christopher O'Connell was elected the firm's new chairman. Berthiaume became president and CEO of Waters in 1994, when it split from Millipore, and he retired as the company's CEO in 2015. He took over as chairman of the firm in 1996. 

Oct 18, 2017

Carlos Bustamante

HumanCode has appointed Carlos Bustamante to its scientific advisory board. Bustamante is currently a professor of computational genomics and biomedical informatics at Stanford University. He will provide scientific guidance to the company following the launch of its BabyGlimpse DNA app for couples to explore the genetics of potential offspring.

Oct 18, 2017

Olivier Elemento and Anshul Kundaje

Freenome has announced the formation of its scientific advisory board including inaugural members Olivier Elemento and Anshul Kundaje.

Elemento is director of the Englander Institute for Precision Medicine, head of the Cancer Systems Biology Laboratory, and associate professor of computational genomics in computational biomedicine at Weill Cornell Medical College. He also serves as co-assistant dean for scientific computing, associate director of the Institute for Computational Biomedicine, and co-chair of the Genetics, Epigenetics and Systems Biology Program at the Meyer Cancer Center. 

Kundaje is an assistant professor of genetics and computer science at Stanford University, focused on computational regulatory genomics. He previously led integrative analysis efforts for the ENCODE Project and the Roadmap Epigenomics Project. 

According to Freenome, the new SAB will work closely with the company's management team to advance the development of the firm's technology platform and commercial disease screening products.

Oct 17, 2017

Kathryn McKenzie

Kathryn McKenzie has been appointed principal accounting officer and vice president of finance at NeoGenomics. Previously, she worked for Chico's FAS in several roles including assistant controller and director of financial reporting and treasury. She was also previously an audit manager for Ernst and Young.

Oct 13, 2017

Fred Hirsch

Biocept said that Fred Hirsch has joined its clinical advisory board. Hirsch is a professor of medicine and pathology at the University of Colorado Cancer Center.


An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.